Correlation Between Tcr2 Therapeutics and Generation Bio
Can any of the company-specific risk be diversified away by investing in both Tcr2 Therapeutics and Generation Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tcr2 Therapeutics and Generation Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tcr2 Therapeutics and Generation Bio Co, you can compare the effects of market volatilities on Tcr2 Therapeutics and Generation Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tcr2 Therapeutics with a short position of Generation Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tcr2 Therapeutics and Generation Bio.
Diversification Opportunities for Tcr2 Therapeutics and Generation Bio
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tcr2 and Generation is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Tcr2 Therapeutics and Generation Bio Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Generation Bio and Tcr2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tcr2 Therapeutics are associated (or correlated) with Generation Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Generation Bio has no effect on the direction of Tcr2 Therapeutics i.e., Tcr2 Therapeutics and Generation Bio go up and down completely randomly.
Pair Corralation between Tcr2 Therapeutics and Generation Bio
If you would invest (100.00) in Tcr2 Therapeutics on December 29, 2024 and sell it today you would earn a total of 100.00 from holding Tcr2 Therapeutics or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Tcr2 Therapeutics vs. Generation Bio Co
Performance |
Timeline |
Tcr2 Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Generation Bio |
Tcr2 Therapeutics and Generation Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tcr2 Therapeutics and Generation Bio
The main advantage of trading using opposite Tcr2 Therapeutics and Generation Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tcr2 Therapeutics position performs unexpectedly, Generation Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generation Bio will offset losses from the drop in Generation Bio's long position.Tcr2 Therapeutics vs. Affimed NV | Tcr2 Therapeutics vs. ADC Therapeutics SA | Tcr2 Therapeutics vs. Agenus Inc | Tcr2 Therapeutics vs. Revolution Medicines |
Generation Bio vs. Monte Rosa Therapeutics | Generation Bio vs. Nkarta Inc | Generation Bio vs. Lyell Immunopharma | Generation Bio vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |